What is the purpose of this trial?
The purpose of this study is to determine whether nivolumab in combination with other therapies is more effective than nivolumab in combination with ipilimumab in treating patients/subjects with advanced renal cell carcinoma.
Ages: 18 years and older
Bristol-Myers Squibb Research and Development
Start Date: 08/28/2017
End Date: 02/01/2020
Last Updated: 03/15/2018
Study HIC#: 2000020529